Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,227 | 1,032 | 99.5% |
| Education | $94.28 | 13 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,519 | 111 | $0 (2024) |
| Amgen Inc. | $1,477 | 86 | $0 (2024) |
| ABBVIE INC. | $1,411 | 82 | $0 (2024) |
| Novo Nordisk Inc | $1,403 | 83 | $0 (2024) |
| Lilly USA, LLC | $960.52 | 55 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $906.88 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $847.73 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $714.22 | 80 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $689.23 | 36 | $0 (2022) |
| Merck Sharp & Dohme LLC | $666.49 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,090 | 173 | ABBVIE INC. ($439.75) |
| 2023 | $2,795 | 163 | ABBVIE INC. ($379.56) |
| 2022 | $2,091 | 125 | Amgen Inc. ($281.69) |
| 2021 | $3,488 | 213 | AbbVie Inc. ($320.37) |
| 2020 | $2,052 | 129 | Novo Nordisk Inc ($249.51) |
| 2019 | $1,956 | 126 | Amarin Pharma Inc. ($255.41) |
| 2018 | $1,353 | 89 | Allergan Inc. ($193.59) |
| 2017 | $495.63 | 27 | Allergan Inc. ($130.28) |
All Payment Transactions
1,045 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Obesity | ||||||
| 12/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: VACCINES | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $4.41 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: UROLOGY | ||||||
| 12/06/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Durable Pump | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.49 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: DERMATOLOGY | ||||||
| 11/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Diabetes Care | ||||||
| 11/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Bone Health | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: PAIN | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Obesity | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,930 | 5,291 | $728,991 | $220,656 |
| 2022 | 25 | 2,518 | 6,109 | $795,596 | $234,548 |
| 2021 | 20 | 2,223 | 5,839 | $722,980 | $212,165 |
| 2020 | 21 | 2,175 | 5,139 | $712,404 | $184,858 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 325 | 1,234 | $412,156 | $114,732 | 27.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 22 | 1,749 | $75,207 | $32,099 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 180 | 180 | $70,740 | $23,733 | 33.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 68 | 68 | $44,252 | $19,106 | 43.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 95 | 97 | $17,751 | $7,250 | 40.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 54 | 68 | $25,024 | $4,963 | 19.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 118 | 121 | $9,922 | $4,095 | 41.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 69 | 69 | $5,658 | $2,335 | 41.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 74 | 222 | $6,438 | $2,113 | 32.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 195 | 218 | $15,478 | $2,027 | 13.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,917 | $1,854 | 37.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 149 | $10,393 | $1,614 | 15.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 211 | 383 | $7,660 | $1,227 | 16.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 191 | 211 | $6,330 | $719.51 | 11.4% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 190 | 310 | $6,200 | $711.70 | 11.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 17 | 19 | $2,850 | $657.78 | 23.1% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 16 | $2,737 | $427.68 | 15.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 11 | 11 | $968.00 | $331.18 | 34.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 17 | 19 | $950.00 | $308.18 | 32.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 11 | 64 | $1,920 | $268.80 | 14.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 72 | $1,440 | $83.63 | 5.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 330 | 1,024 | $342,016 | $91,377 | 26.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 24 | 2,103 | $90,429 | $35,940 | 39.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 257 | 257 | $101,001 | $34,566 | 34.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 137 | 261 | $96,048 | $25,033 | 26.1% |
About Dr. Joseph Kagan, MD
Dr. Joseph Kagan, MD is a Internal Medicine healthcare provider based in Brockton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851388029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Kagan, MD has received a total of $17,322 in payments from pharmaceutical and medical device companies, with $3,090 received in 2024. These payments were reported across 1,045 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($17,227).
As a Medicare-enrolled provider, Kagan has provided services to 8,846 Medicare beneficiaries, totaling 22,378 services with total Medicare billing of $852,226. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Brockton, MA
- Active Since 10/04/2005
- Last Updated 08/16/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1851388029
Products in Payments
- VRAYLAR (Drug) $1,054
- NURTEC ODT (Drug) $745.73
- EVENITY (Biological) $528.98
- NEXLETOL (Drug) $528.48
- XIFAXAN (Drug) $490.24
- EMGALITY (Drug) $481.84
- ENTRESTO (Drug) $443.18
- XARELTO (Drug) $440.52
- FARXIGA (Drug) $439.86
- ELIQUIS (Drug) $431.28
- Ozempic (Drug) $426.04
- UBRELVY (Drug) $418.16
- Vascepa (Drug) $417.80
- Wegovy (Drug) $403.67
- CHANTIX (Drug) $400.42
- Aimovig (Biological) $376.12
- TRELEGY ELLIPTA (Drug) $373.40
- JANUVIA (Drug) $352.79
- Otezla (Drug) $316.21
- STIOLTO RESPIMAT (Drug) $295.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brockton
Bahige Asaker, Do, DO
Internal Medicine — Payments: $17,629
Andrew Kriegel, Md, MD
Internal Medicine — Payments: $12,403
Dino Constantinou, Md, MD
Internal Medicine — Payments: $6,970
Elisa Mulcahy, Md, MD
Internal Medicine — Payments: $6,670
David Mudd, Md, MD
Internal Medicine — Payments: $6,486
Robert Covett, D.o, D.O
Internal Medicine — Payments: $6,333